Suppr超能文献

补充复合膳食碳水化合物和肠道微生物群在促进肥胖人群心脏代谢和免疫健康中的作用:来自健康非肥胖个体的经验教训。

The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals.

作者信息

Vinke Petra C, El Aidy Sahar, van Dijk Gertjan

机构信息

Department of Behavioral Neuroscience, Groningen Institute for Evolutionary Life Sciences (GELIFES) - Neurobiology, University of Groningen, Groningen, Netherlands.

Microbial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Groningen, Netherlands.

出版信息

Front Nutr. 2017 Jul 24;4:34. doi: 10.3389/fnut.2017.00034. eCollection 2017.

Abstract

Dietary supplementation with complex carbohydrates is known to alter the composition of gut microbiota, and optimal implementation of the use of these so called "prebiotics" could be of great potential in prevention and possibly treatment of obesity and associated cardiometabolic and inflammatory diseases changes in the gut microbiota. An alternative to this "microbiocentric view" is the idea that health-promoting effects of certain complex carbohydrates reside in the host, and could secondarily affect the diversity and abundance of gut microbiota. To circumvent this potential interpretational problem, we aimed at providing an overview about whether and how dietary supplementation of different complex carbohydrates changes the gut microbiome in healthy non-obese individuals. We then reviewed whether the reported changes in gut bacterial members found to be established by complex carbohydrates would benefit or harm the cardiometabolic and immunological health of the host taking into account the alterations in the microbiome composition and abundance known to be associated with obesity and its associated disorders. By combining these research areas, we aimed to give a better insight into the potential of (foods containing) complex carbohydrates in the treatment and prevention of above-mentioned diseases. We conclude that supplemental complex carbohydrates that increase Bifidobacteria and Lactobacilli, without increasing the deleterious , are most likely promoting cardiometabolic and immunological health in obese subjects. Because certain complex carbohydrates also affect the host's immunity directly, it is likely that host-microbiome interactions in determination of health and disease characteristics are indeed bidirectional. Overall, this review article shows that whereas it is relatively clear in which direction supplemental fermentable carbohydrates can alter the gut microbiome, the relevance of these changes regarding health remains controversial. Future research should take into account the different causes of obesity and its adverse health conditions, which in turn have drastic effects on the microbiome balance.

摘要

已知膳食补充复合碳水化合物会改变肠道微生物群的组成,而这些所谓“益生元”的最佳使用方式在预防甚至可能治疗肥胖及相关的心脏代谢和炎症性疾病方面可能具有巨大潜力,因为肠道微生物群会发生变化。与这种“以微生物为中心的观点”不同的是,另一种观点认为某些复合碳水化合物的健康促进作用存在于宿主中,并可能继而影响肠道微生物群的多样性和丰度。为了避免这个潜在的解释问题,我们旨在概述不同复合碳水化合物的膳食补充是否以及如何改变健康非肥胖个体的肠道微生物组。然后,我们回顾了复合碳水化合物所导致的肠道细菌成员的变化是否会对宿主的心脏代谢和免疫健康有益或有害,同时考虑到已知与肥胖及其相关疾病有关的微生物组组成和丰度的改变。通过结合这些研究领域,我们旨在更好地了解复合碳水化合物(及其所含食物)在治疗和预防上述疾病方面的潜力。我们得出结论,补充能增加双歧杆菌和乳酸杆菌而不增加有害菌的复合碳水化合物最有可能促进肥胖受试者的心脏代谢和免疫健康。由于某些复合碳水化合物也会直接影响宿主的免疫力,因此在决定健康和疾病特征方面,宿主与微生物组之间的相互作用很可能是双向的。总体而言,这篇综述文章表明,虽然补充可发酵碳水化合物会在哪个方向改变肠道微生物组相对明确,但这些变化对健康的相关性仍存在争议。未来的研究应考虑肥胖及其不良健康状况的不同成因,而这些反过来又会对微生物组平衡产生巨大影响。

相似文献

3
Prebiotic effects: metabolic and health benefits.
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
4
Nutrition and Microbiome.
Handb Exp Pharmacol. 2022;274:57-73. doi: 10.1007/164_2022_588.
7
Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children.
EBioMedicine. 2015 Jul 10;2(8):968-84. doi: 10.1016/j.ebiom.2015.07.007. eCollection 2015 Aug.
9
Targeting the Gut Microbiome to Treat Cardiometabolic Disease.
Curr Atheroscler Rep. 2024 Feb;26(2):25-34. doi: 10.1007/s11883-023-01183-2. Epub 2024 Jan 5.
10
Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components.
Am J Clin Nutr. 2014 Jul;100 Suppl 1:369S-77S. doi: 10.3945/ajcn.113.071639. Epub 2014 Jun 4.

引用本文的文献

4
Associations between the Gut Microbiota, Urinary Metabolites, and Diet in Women during the Third Trimester of Pregnancy.
Curr Dev Nutr. 2022 Dec 24;7(4):100025. doi: 10.1016/j.cdnut.2022.100025. eCollection 2023 Apr.
5
Personalized nutrition, microbiota, and metabolism: A triad for eudaimonia.
Front Mol Biosci. 2022 Oct 18;9:1038830. doi: 10.3389/fmolb.2022.1038830. eCollection 2022.
7
A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children.
Front Nutr. 2022 Aug 4;9:922993. doi: 10.3389/fnut.2022.922993. eCollection 2022.
8
is not always associated with adverse health effects in the Guangdong Gut Microbiome Project.
PeerJ. 2021 Aug 18;9:e12033. doi: 10.7717/peerj.12033. eCollection 2021.
9
Plant Prebiotics and Their Role in the Amelioration of Diseases.
Biomolecules. 2021 Mar 16;11(3):440. doi: 10.3390/biom11030440.

本文引用的文献

1
Gastrointestinal Organoids: Understanding the Molecular Basis of the Host-Microbe Interface.
Cell Mol Gastroenterol Hepatol. 2016 Dec 19;3(2):138-149. doi: 10.1016/j.jcmgh.2016.11.007. eCollection 2017 Mar.
2
β2→1-Fructans Modulate the Immune System in a Microbiota-Dependent and -Independent Fashion.
Front Immunol. 2017 Feb 16;8:154. doi: 10.3389/fimmu.2017.00154. eCollection 2017.
5
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome.
Nature. 2016 Jun 9;534(7606):213-7. doi: 10.1038/nature18309.
6
Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome.
Eur J Pharmacol. 2016 Aug 15;785:207-214. doi: 10.1016/j.ejphar.2016.04.021. Epub 2016 Apr 12.
7
Organoids as an in vitro model of human development and disease.
Nat Cell Biol. 2016 Mar;18(3):246-54. doi: 10.1038/ncb3312.
8
Exploring the Microbiome in Heart Failure.
Curr Heart Fail Rep. 2016 Apr;13(2):103-9. doi: 10.1007/s11897-016-0285-9.
9
Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature.
Diabetes Obes Metab. 2016 May;18(5):444-53. doi: 10.1111/dom.12637. Epub 2016 Mar 4.
10
Gut microbiota imbalance and colorectal cancer.
World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验